Suppr超能文献

切除的非小细胞肺癌中阳性淋巴结数量的意义

Significance of the number of positive lymph nodes in resected non-small cell lung cancer.

作者信息

Fukui Takayuki, Mori Shoichi, Yokoi Kohei, Mitsudomi Tetsuya

机构信息

Department of Thoracic Surgery, Aichi Cancer Center Hospital, Nagoya, Japan.

出版信息

J Thorac Oncol. 2006 Feb;1(2):120-5.

Abstract

BACKGROUND

In the current tumor, node, metastasis (TNM) classification of lung cancer, N status is defined by the anatomic extent of lymph node metastases. In this study, we evaluated the prognostic significance of the number of positive lymph nodes in resected non-small cell lung cancer.

METHODS

We retrospectively studied 289 patients with non-small cell lung cancer who underwent surgery, and we compared the prognostic significance of the number of positive nodes with the pN number by using multivariate analysis. Patients were classified into four groups according to the number of positive nodes: those without nodal metastasis were n, those with one to three positive nodes were n, those with four to six were n, and those with more than seven were n.

RESULTS

The 5-year survival rate was 77% in the n patients, 58% in n, 42% in n, and 6% in n, which indicates that an increased number of positive lymph nodes was associated with poor prognosis. Among the pN2 patients, the n group had a better survival rate than the n and n groups. Multivariate analysis showed that the number of positive nodes was a significant prognostic factor, equal to the currently used pN number. Hazard ratios for pN1 and pN2 with respect to pN0 were 2.13 and 3.49; and 2.07, 3.03, and 10.4 for n, n, and n with respect to n. In addition, we found that our classification could reflect the better prognoses of skip or single-station nodal metastases.

CONCLUSION

The number of positive lymph nodes is a strong independent prognostic factor in non-small cell lung cancer and may add new information to the pN categories of the current TNM classification.

摘要

背景

在当前肺癌的肿瘤、淋巴结、转移(TNM)分类中,N分期是由淋巴结转移的解剖范围定义的。在本研究中,我们评估了切除的非小细胞肺癌中阳性淋巴结数量的预后意义。

方法

我们回顾性研究了289例接受手术的非小细胞肺癌患者,并通过多因素分析比较了阳性淋巴结数量与pN分期的预后意义。根据阳性淋巴结数量将患者分为四组:无淋巴结转移的为n组,有1至3个阳性淋巴结的为n组,有4至6个的为n组,有7个以上的为n组。

结果

n组患者的5年生存率为77%,n组为58%,n组为42%,n组为6%,这表明阳性淋巴结数量增加与预后不良相关。在pN2患者中,n组的生存率高于n组和n组。多因素分析显示,阳性淋巴结数量是一个显著的预后因素,与目前使用的pN分期相当。pN1和pN2相对于pN0的风险比分别为2.13和3.49;n组、n组和n组相对于n组的风险比分别为2.07、3.03和10.4。此外,我们发现我们的分类可以反映跳跃性或单站淋巴结转移的较好预后。

结论

阳性淋巴结数量是非小细胞肺癌中一个强大的独立预后因素,可能为当前TNM分类的pN类别增加新的信息。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验